Power Law company profile

NGM Biopharmaceuticals

Biotech & Life Sciences · South San Francisco, United States · Founded 2007 · IPO 2019 Thoroughbred

← All companies

A public taster of the full Dealroom platform — request a demo to explore live financials, founders, funding history, and market intelligence.

Revenue

$4.4M

Latest reported FY

Investors

8 investors on NGM Biopharmaceuticals's cap table

Sourced from Dealroom's funding history. Tap any card for that investor's profile.

Series A 3 investors entered at this stage

Series B+ 5 investors entered at this stage

Global footprint

AI talent share

2.5% of workforce is AI talent
(2 of 81 staff)

Core AI00%

Other AI22.47%

Non-AI workforce7997.53%

Web traffic by country

5.1K monthly visits
across markets

🇺🇸 United States90.2%

🇦🇺 Australia7.8%

Top 2 markets shown

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Open in Dealroom Book a demo